Programa de Pós-graduação em Ciências da Saúde PPGCS, Centro de Ciências Biológicas e da Saúde CCBS, Pontifícia Universidade Católica do Paraná PUCPR, Curitiba, PR, Brazil.
J Pediatr (Rio J). 2013 Mar-Apr;89(2):137-44. doi: 10.1016/j.jped.2013.03.010.
Cleft lip with or without cleft palate (CL±P) or cleft palate (CP) are groups of malformations named orofacial clefts (OC), which are the second leading cause of birth defects. This study aimed to analyze clinical and epidemiological features of Brazilian patients with OC, studying cases treated in the reference center of the state of Paraná (PR).
2,356 charts were reviewed and 1,838 were evaluated by the same clinical geneticist. Data were collected in the reference center, and compared with those of the Health Department of the state of Paraná. Clinical characteristics, presence of other anomalies, and birth prevalence were evaluated.
389 (21.2%) patients had CP, 437 (23.8%) had cleft lip (CL), and 1,012 (55%) had cleft lip and palate (CLP). Syndromic OC were identified in 15.3% of patients, 10.4% of patients with CL±P, and 33.9% of patients with CP. Common additional anomalies were: central nervous system, limbs, cardiovascular, and musculoskeletal defects. The number of syndromic cases was lower when clinical evaluation was performed by other medical specialists when compared to that of the clinical geneticist. Birth prevalence was 1/1,010 live births. Lack of notification with the national birth registry was observed in 49.9% of CL±P. The present data suggests a decrease of 18.52% in the prevalence of non-syndromic OC after folic acid fortification in Brazil.
Better understanding of clinical and epidemiological aspects of OC is crucial to improve the understanding of pathogenesis, promote preventive strategies, and guide clinical care, including the presence of clinical geneticists in the multidisciplinary team for OC treatment.
唇裂伴或不伴腭裂(CL±P)或腭裂(CP)是一组命名为口腔颌面裂(OC)的畸形,是出生缺陷的第二大主要原因。本研究旨在分析巴西 OC 患者的临床和流行病学特征,研究在巴西南里奥格兰德州参考中心治疗的病例。
共回顾了 2356 份病历,其中 1838 份由同一位临床遗传学家进行评估。数据由参考中心收集,并与巴西南里奥格兰德州卫生部的数据进行比较。评估了临床特征、是否存在其他异常和出生流行率。
389 例(21.2%)患者为 CP,437 例(23.8%)为 CL,1012 例(55%)为 CLP。15.3%的患者为综合征性 OC,10.4%的 CL±P 患者和 33.9%的 CP 患者为综合征性 OC。常见的附加异常有:中枢神经系统、四肢、心血管和肌肉骨骼缺陷。与临床遗传学家相比,其他医学专家进行临床评估时,综合征病例的数量较低。出生流行率为每 1010 例活产儿 1 例。CL±P 中有 49.9%未向国家出生登记处报告。本研究数据表明,巴西叶酸强化后,非综合征性 OC 的患病率下降了 18.52%。
更好地了解 OC 的临床和流行病学方面对于提高对发病机制的认识、促进预防策略以及指导临床护理至关重要,包括在 OC 治疗的多学科团队中配备临床遗传学家。